Centre for MEGA Epidemiology, University of Melbourne, Melbourne, Australia.
J Allergy Clin Immunol. 2011 Oct;128(4):782-788.e9. doi: 10.1016/j.jaci.2011.06.038. Epub 2011 Aug 6.
Identification of children at risk of developing asthma provides a window of opportunity for risk-reducing interventions. Allergen sensitization might identify high-risk children.
We sought to determine whether skin prick tests (SPTs) to individual allergens up to age 2 years predict wheeze at age 12 years.
In a birth cohort of 620 children oversampled for familial allergy, sensitization was assessed by using SPTs (monosensitized, polysensitized, or either) to 6 allergens at ages 6, 12, and 24 months. Wheeze and eczema were recorded 18 times during the first 2 years. Current wheeze was recorded at age 12 years. Adjusted associations were evaluated by multiple logistic regression.
A positive SPT to house dust mite (HDM) at age 1 or 2 years predicted wheeze at age 12 years (adjusted odds ratio: 1 year, 3.31 [95% CI 1.59-6.91]; 2 years, 6.37 [95% CI, 3.48-11.66]). Among wheezy 1-year-olds, those who were HDM sensitized had a 75% (95% CI, 51% to 91%) probability of wheeze at age 12 years compared with a 36% (95% CI, 23% to 50%) probability among those not sensitized. Among eczematous 1-year-olds, those who were HDM sensitized had a 67% (95% CI, 45% to 84%) probability of wheeze at age 12 years compared with a 35% (95% CI, 25% to 45%) probability among those not sensitized. Among 1-year-old children with both eczema and wheeze, the probability of wheeze at age 12 years was 64% (95% CI, 35% to 87%) if HDM sensitized and 50% (95% CI, 26% to 74%) if not.
HDM sensitization at age 1 or 2 years in wheezing and eczematous children at increased familial allergy risk predicts asthma and may inform management of these high-risk groups.
识别有发展为哮喘风险的儿童为减少风险的干预措施提供了机会。过敏原致敏可能会识别出高风险的儿童。
我们旨在确定 2 岁以下的皮肤点刺试验(SPT)对个体过敏原的检测是否可预测 12 岁时的喘息。
在一个家族性过敏的 620 名儿童的抽样队列中,通过 SPT 评估致敏情况(单敏、多敏或两者),时间为 6 个月、12 个月和 24 个月。在最初的 2 年内,18 次记录喘息和湿疹。12 岁时记录当前喘息情况。通过多变量逻辑回归评估调整后的关联。
1 岁或 2 岁时对屋尘螨(HDM)的 SPT 阳性预测 12 岁时的喘息(调整后的优势比:1 岁,3.31 [95% CI 1.59-6.91];2 岁,6.37 [95% CI,3.48-11.66])。在喘息 1 岁的儿童中,HDM 致敏的儿童在 12 岁时喘息的可能性为 75%(95% CI,51%至 91%),而未致敏的儿童的可能性为 36%(95% CI,23%至 50%)。在 1 岁时有湿疹的儿童中,HDM 致敏的儿童在 12 岁时喘息的可能性为 67%(95% CI,45%至 84%),而未致敏的儿童的可能性为 35%(95% CI,25%至 45%)。在 1 岁时同时患有湿疹和喘息的儿童中,如果 HDM 致敏,12 岁时喘息的可能性为 64%(95% CI,35%至 87%),如果未致敏,可能性为 50%(95% CI,26%至 74%)。
在家族性过敏风险增加的喘息和湿疹儿童中,1 岁或 2 岁时对 HDM 的致敏预测哮喘,并可能为这些高风险群体的管理提供信息。